CXCL13 as a Biomarker: Background and Utility in Multiple Sclerosis

CXCL13 is a chemokine which is upregulated within the CNS in multiple sclerosis, Lyme neuroborreliosis, and other inflammatory diseases and is increasingly clinically useful as a biomarker. This review provides background for understanding its function in the immune system and its relationship to ec...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrew R. Pachner, Steven Pike, Andrew D. Smith, Francesca Gilli
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/14/12/1541
Tags: Add Tag
No Tags, Be the first to tag this record!